Literature DB >> 7109792

[Animal experiments to assess the risk of cancer in the stomach after vagotomy (author's transl)].

P Schlag, E Weber, H Meister, H Meyer.   

Abstract

To assess the possible risk of cancer in the operated stomach, the influence of truncal vagotomy combined with different operative drainage procedures (pyloroplasty, gastro-enterostomy without entero-anastomosis, Roux-en-Y gastro-enterostomy) was studied in animal experiments. The aim of the study was to determine whether, compared to controls an earlier and higher incidence of precancerous epithelial lesions or cancers in the stomach occurs in vagotomized animals after oral administration of carcinogens (MNNG). To consider conditions, that may predispose to in vivo formation of carcinogenic N-nitroso compounds, bacterial flora and intragastric nitrite concentration were measured and compared in the various operative groups. The severity of induced epithelial lesions and the quantity of bacterial growth and nitrite concentration in the gastric juice were influenced, apart from the reduction of acid output after vagotomy, mainly by prolonged gastric stasis or the degree of enterogastric reflux. The results suggest that there is probably no increased risk of cancer following vagotomy, if sufficient gastric clearance is guaranteed and enterogastric reflux is largely excluded.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7109792     DOI: 10.1007/BF01237456

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  23 in total

1.  Sequential morphological changes in N-methyl-N'-nitro-N-nitrosoguanidine carcinogenesis in the glandular stomach of rats.

Authors:  T Saito; K Inokuchi; S Takayama; T Sugimura
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

Review 2.  Formation of N-nitroso compounds: chemistry, kinetics, and in vivo occurrence.

Authors:  S S Mirvish
Journal:  Toxicol Appl Pharmacol       Date:  1975-03       Impact factor: 4.219

3.  [Bacterial flora and nitrite production in the stomach after gastroenterostomy. Experimental aspects of the pathogenesis of carcinoma in the operated stomach (author's transl)].

Authors:  P Schlag; W Wonka; H Meyer; G Feyerabend; P Merkle
Journal:  Langenbecks Arch Chir       Date:  1977-11-04

4.  [Cancer risk of the stomach resected for ulcer. The role of duodenogastric reflux (author's transl)].

Authors:  K Dahm; R Eichen; H Mitschke
Journal:  Langenbecks Arch Chir       Date:  1977-11-04

5.  [Carcinoma after gastric operations (author's transl)].

Authors:  G Clémençon; R Baumgartner; E Leuthold; G Miller; A Neiger
Journal:  Dtsch Med Wochenschr       Date:  1976-07-02       Impact factor: 0.628

Review 6.  Experimental gastric carcinogenesis.

Authors:  S P Bralow
Journal:  Digestion       Date:  1972       Impact factor: 3.216

7.  Relationship between vagotomy, peptic ulcer and gastric adenocarcinoma in rats fed 2,7-diacetylaminogluorene.

Authors:  K Kowalewski
Journal:  Can J Surg       Date:  1973-05       Impact factor: 2.089

8.  Reaction of N-methyl-N'-nitro-N-nitroguanidine and N-methyl-N-nitroso-p-toluenesulfonamide with DNA in vitro.

Authors:  D R McCalla
Journal:  Biochim Biophys Acta       Date:  1968-01-29

9.  [Bacteriology of the stomach after operation (author's transl)].

Authors:  V Schumpelick; H H Schassan
Journal:  Langenbecks Arch Chir       Date:  1980

10.  [Influence of duodenal reflux on the epithelium of the gastroenteral anastomosis (author's transl)].

Authors:  P Schlag; H Meister; G Feyerabend; P Merkle
Journal:  Langenbecks Arch Chir       Date:  1977-12-14
View more
  2 in total

1.  Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation.

Authors:  C Toftgaard
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

Review 2.  The Role of the Vagus Nerve in Cancer Prognosis: A Systematic and a Comprehensive Review.

Authors:  Marijke De Couck; Ralf Caers; David Spiegel; Yori Gidron
Journal:  J Oncol       Date:  2018-07-02       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.